A phase II clinical trial with cytotropic heterogeneous molecular lipids (CHML) for patients with hepatic malignancies.
A phase II clinical trial with cytotropic heterogeneous molecular lipids (CHML) for patients with hepatic malignancies.
复制标题
针对肝恶性肿瘤患者使用亲细胞异质分子脂质 (CHML) 进行的 II 期临床试验。
作者：
Chen,Xian-Cheng;Yu,Bo;Dong,Jing-Cheng;Gu,Yu-Xiang;Chen,Lei;Wu,Qing-Zhen;Hou,Nan-Ping;Liu,Jun-Xiong;Xu,Jia-Ting;Jin,Rui-Xie;Jin,Guan-Qiu;Yang,Xue-Dong;Cao,Yong-Wei;Tan,Jia-Ju;Zhu,Bin;Shen,Jia-Chuan;Xu,Zheng;Varticovski,Ly
